This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Universite Paris Cité. Active years: 2020-2023.
Company Filing History:




Years Active: 2020-2023
Title: Camille Faure: Innovator in Cancer Diagnosis and Treatment
Introduction
Camille Faure is a notable inventor based in Paris, France. He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of HER2-dependent cancers. With a total of 3 patents, Faure's work has the potential to impact the lives of many patients.
Latest Patents
One of Faure's latest patents focuses on the diagnosis and/or prognosis of HER2-dependent cancer using specific microRNAs as biomarkers. This invention outlines a method that involves measuring the levels of selected miRNAs in a sample from a subject and comparing these levels to reference values. The findings can help in diagnosing or prognosticating HER2-dependent cancer. Another significant patent involves the treatment of HER2-dependent cancer using agents that modulate the activity of specific miRNAs. This innovative approach aims to provide new therapeutic options for patients suffering from this type of cancer.
Career Highlights
Throughout his career, Camille Faure has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and the National Institute of Health and Medical Research. His experience in these institutions has allowed him to develop and refine his innovative ideas in cancer research.
Collaborations
Faure has collaborated with talented individuals in his field, including Sandrine Bourdoulous and Anaïs Domingot. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Camille Faure's contributions to cancer diagnosis and treatment through his innovative patents highlight his dedication to improving patient outcomes. His work continues to pave the way for advancements in the medical field.